ArticleBMC infectious diseases2025
Malaria vector control strategies in Pakistan: a scoping review.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Malaria Epidemiology andTropical medicine and infectious disease · 2026Article
- Prevalence, Associated Risk Factors, and the Impact of Malaria on Anemia in Pregnant Women Attending ANC in North Gondar Zone, Northern Ethiopia.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria remains a significant public health concern in Pakistan due to its subtropical climate and diverse array of vectors, which contribute to periodic outbreaks and challenges in disease control. Recent outbreaks-particularly in 2022-along with the rising incidence of Plasmodium falciparum and growing resistance of Anopheles mosquito vector to existing control methods, highlight a critical gap in understanding the effectiveness of current malaria vector control strategies. This article is a scoping review of published literature on malaria prevention methods with a focus on World Health Organization (WHO) outlined interventions in the endemic region of the lower middle-income country, Pakistan.
methodsRelevant articles published in all languages before September 2023 were reviewed. All the articles were obtained from PubMed, Scopus, CINAHL, Embase and Google Scholar. Four independent reviewers performed the selection and characterization of articles based on defined inclusion criteria. The data collected were extracted and analyzed by province, vector, and vector control methods according to WHO recommendations.
resultsA total of 46 articles reporting surveillance findings on vector control methods in Pakistan were found. Based on WHO recommendations, the reported strategies included insecticide-treated nets (ITN) (29.79%), indoor residual spraying (IRS) (29.79%), spatial spraying (12.77%), spatial/airborne repellents (4.26%), larval source management (4.26%) and house modifications (4.26%). In contrast to Khyber Pakhtunkhwa, which employs ITN (55%) as the primary vector control method, Punjab was found to use IRS as the main method of vector control (50%).
conclusionThis review highlights the current strategies for controlling malaria vectors and the strategies used in the past for outbreaks in Pakistan. This review identifies a notable increase in the use of insecticide-treated nets (ITNs) over time and highlights differences in the implementation of vector control strategies across provinces in Pakistan. Current practices and their contrast to WHO guidelines are illustrated. It helps us understand the need for improved research and development with precise reporting. These findings can serve as a reference for guiding policy decisions and improving malaria control efforts in endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.